Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday.

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than ...